Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors
Clinical trial NCT03472352 · UNKNOWN
Trial details
- NCT number
- NCT03472352
- Sponsor
- Hangzhou Converd Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2019-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.